CSTONE AND KIMIA THERAPEUTICS HAVE ENTERED A CLINICAL DEVELOPMENT COLLABORATION TO ADVANCE A NOVEL DRUG CANDIDATE TARGETING REPAIR PATHWAYS CRITICAL FOR SOLID TUMOR SURVIVAL
CSRD. CBAM. California's climate disclosure rules.
If your team is trying to keep up with sustainability reporting and where AI can (and can’t) help, join us and Tracera on Nov 10 for a free webinar.
Register:
CSL REAFFIRMS ITS FY27 GUIDANCE, SAYING IT EXPECTS PRE-TAX TRANSFORMATION SAVINGS TO RISE TO $400 MLN IN FY27 AND UP TO $550 MLN IN FY28, AND THAT IT WILL PROGRESS AN A$1 BLN BUYBACK IN FY26 AND AN A$1.1 BLN BUYBACK IN FY27
cSigma’s Atlas can support both traditional debt financing and stablecoin capital across multiple blockchain networks through a unified ledger & an interactive capital management interface.
CSX Q3 2026 REVENUE $4.02 BLN, ABOVE ESTIMATE OF $3.96 BLN, WITH EPS 57 CENTS, ABOVE ESTIMATE OF 53 CENTS, AND OPERATING INCOME $1.57 BLN, ABOVE ESTIMATE OF $1.48 BLN